Press Releases - 2022-10-31

Date	Title	Company
31-Oct-2022	Biophytis publishes its key financial figures as at 30 June 2022, announces a restatement of the financial statements published as of December 31st, 2021 and provides an update on the oper	Biophytis
31-Oct-2022	Aptar Pharma Completes First Phase of Global Expansion Program to Meet Growing Customer Capacity Needs for Injectable Drug Delivery	Aptar Pharma
31-Oct-2022	Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System	Beckman Coulter Life Sciences
31-Oct-2022	‘Healthcare Shouldn’t be about Treatment’: Can Preventive Care Put an End to Disease and Virus Outbreaks?	Unimed Procurement Services
31-Oct-2022	Skin Perfusion Pressure Testing Devices Market Analysis, Future Growth, Business Prospects, Size, Share, Development, Forecast to 2030	MARKITWIRED
31-Oct-2022	A&M FORMS COALITION WITH ROYAL COLLEGE OF ART AND NON-PROFIT FUZZY TO LAUNCH HEALTHCARE INNOVATION LAB	Alvarez & Marsal
31-Oct-2022	Negative Pressure Wound Therapy Market Size to Reach US$ 9.9 Bn by 2032 \| CAGR of 5.2%	MARKITWIRED
31-Oct-2022	Light Therapy Market Business Growth, Size and Comprehensive Research Study Forecast by 2031-end	MARKITWIRED
31-Oct-2022	SynBiotic SE completes successfully capital increase and places all new shares	SynBiotic SE
31-Oct-2022	Bone Growth Stimulators Market \| Size, Top Key Players, Latest Trends, Regional Insights & Global Industry Dynamics	MARKITWIRED
31-Oct-2022	Quadriplegia Treatment Market size worth US$ 2,324.4 Mn by 2032 \| Future Market Insights	MARKITWIRED
31-Oct-2022	Proteomics Market size Is Expected To See a growth of 13.5% \| Future Market Insights	MARKITWIRED
31-Oct-2022	Teleradiology Services Market size to grow at a rate of 21.0% by 2026-end \| Get Customized Reports	MARKITWIRED
31-Oct-2022	Portable Oxygen Concentrators Market size expected to reach US$ 1.9 Bn by the end of 2022 – Exclusive Report by FMI	MARKITWIRED
31-Oct-2022	Preclinical Data Demonstrates SonoTran® Increased Delivery and Efficacy of ADCT-601 in Human Renal Cancer Model	OxSonics Therapeutics
31-Oct-2022	Molecure Third Quarter 2022 Pipeline Highlights and Financial Results	Molecure
31-Oct-2022	European Medicines Agency Validates Santhera’s Marketing Authorization Application for Vamorolone in Duchenne Muscular Dystrophy	Santhera Pharmaceuticals
31-Oct-2022	Santhera Announces Half-Year 2022 Financial Results and Provides Corporate Update	Santhera Pharmaceuticals
31-Oct-2022	GPs to be able to offer patients ‘digital pill’ for mental health	Wysa
31-Oct-2022	Preclinical Data Demonstrates SonoTran® Increased Delivery and Efficacy of ADCT-601 in Human Renal Cancer Model	B3C newswire